NJ State Employees Deferred Compensation Plan - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$557,511
-2.7%
8,3000.0%0.08%
+2.4%
Q2 2023$572,949
+43.2%
8,3000.0%0.08%
+33.9%
Q1 2023$400,226
-3.4%
8,3000.0%0.06%
-7.5%
Q4 2022$414,336
+22.2%
8,3000.0%0.07%
+15.5%
Q3 2022$339,0008,3000.06%
Other shareholders
LEGEND BIOTECH CORP shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 814,586$54,715,74220.16%
HHLR ADVISORS, LTD. 6,436,533$432,341,9229.65%
Paradigm Biocapital Advisors LP 2,025,480$136,051,4929.23%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,123,828$75,487,5279.13%
RA Capital Management 6,264,707$420,800,3698.28%
Iron Triangle Partners LP 452,629$30,403,0904.44%
Nicholas Investment Partners, LP 593,010$39,832,4822.98%
Old Well Partners, LLC 45,200$3,036,0842.63%
Avidity Partners Management LP 967,000$64,953,3902.62%
E Fund Management (Hong Kong) Co., Ltd. 52,759$3,5442.23%
View complete list of LEGEND BIOTECH CORP shareholders